Krafft M P, Riess J G
Institut Charles-Sadron (UPR-CNRS 22), Strasbourg, France.
Biochimie. 1998 May-Jun;80(5-6):489-514. doi: 10.1016/s0300-9084(00)80016-4.
Fluorocarbons and fluorocarbon moieties are uniquely characterized by very strong intramolecular bonds and very weak intermolecular interactions. This results in a combination of exceptional thermal, chemical and biological inertness, low surface tension, high fluidity, excellent spreading characteristics, low solubility in water, and high gas dissolving capacities, which are the basis for innovative applications in the biomedical field. Perfluoroalkyl chains are larger and more rigid than their hydrogenated counterparts. They are considerably more hydrophobic, and are lipophobic as well. A large variety of well-defined, modular fluorinated surfactants whose polar head groups consist of polyols, sugars, sugar phosphates, amino acids, amine oxides, phosphocholine, phosphatidylcholine, etc, has recently been synthesized. Fluorinated surfactants are significantly more surface active than their hydrocarbon counterparts, both in terms of effectiveness and of efficiency. Despite this, they are less hemolytic and less detergent. Fluorosurfactants appear unable to extract membrane proteins. Fluorinated chains confer to surfactants a powerful driving force for collecting and organizing at interfaces. As compared to non-fluorinated analogs, fluorosurfactants have also a much stronger capacity to self-aggregate into discrete molecular assemblies when dispersed in water and other solvents. Even very short, single-chain fluorinated amphiphiles can form highly stable, heat-sterilizable vesicles, without the need for supplementary associative interactions. Sturdy microtubules were obtained from non-chiral, non-hydrogen bonding single-chain fluorosurfactants. Fluorinated amphiphiles can be used to engineer a variety of colloidal systems and manipulate their morphology, structure and properties. Stable fluorinated films, membranes and vesicles can also be prepared from combinations of standard surfactants with fluorocarbon/hydrocarbon diblock molecules. In bilayer membranes made from fluorinated amphiphiles the fluorinated tails segregate to form an internal teflon-like hydrophobic and lipophobic film that increases the stability of the membrane and reduces its permeability. This fluorinated film can also influence the behavior of fluorinated vesicles in a biological milieu. For example, it can affect the in vivo recognition and fate of particles, or the enzymatic hydrolysis of phospholipid components. Major applications of fluorocarbons currently in advanced clinical trials include injectable emulsions for delivering oxygen to tissues at risk of hypoxia; a neat fluorocarbon for treatment of acute respiratory failure by liquid ventilation; and gaseous fluorocarbon-stabilized microbubbles for use as contrast agents for ultrasound imaging. Fluorosurfactants also allow the preparation of a range of stable direct and reverse emulsions, microemulsions, multiple emulsions, and gels, some of which may include fluorocarbon and hydrocarbon and aqueous phases simultaneously. Highly fluorinated systems have potential for the delivery of drugs, prodrugs, vaccines, genes, markers, contrast agents and other materials.
碳氟化合物和碳氟基团具有独特的特征,其分子内键非常强,分子间相互作用非常弱。这导致了其具有出色的热、化学和生物惰性、低表面张力、高流动性、优异的铺展特性、在水中的低溶解度以及高气体溶解能力等特性的组合,这些特性是生物医学领域创新应用的基础。全氟烷基链比其氢化对应物更大且更刚性。它们的疏水性更强,并且也具有疏脂性。最近已经合成了多种定义明确的模块化氟化表面活性剂,其极性头部基团由多元醇、糖、糖磷酸盐、氨基酸、氧化胺、磷酸胆碱、磷脂酰胆碱等组成。氟化表面活性剂在有效性和效率方面都比其烃类对应物具有显著更高的表面活性。尽管如此,它们的溶血作用较小且去污性较低。含氟表面活性剂似乎无法提取膜蛋白。氟化链赋予表面活性剂在界面处聚集和组织的强大驱动力。与非氟化类似物相比,氟化表面活性剂在分散于水和其他溶剂中时也具有更强的自聚集形成离散分子聚集体的能力。即使是非常短的单链氟化两亲物也可以形成高度稳定、可热灭菌的囊泡,而无需额外的缔合相互作用。从非手性、非氢键单链氟化表面活性剂中获得了坚固的微管。氟化两亲物可用于设计各种胶体系统并操纵其形态、结构和性质。稳定的氟化膜、膜和囊泡也可以由标准表面活性剂与碳氟化合物/烃二嵌段分子的组合制备。在由氟化两亲物制成的双层膜中,氟化尾部会分离形成类似内部聚四氟乙烯的疏水和疏脂膜,从而增加膜的稳定性并降低其渗透性。这种氟化膜也可以影响氟化囊泡在生物环境中的行为。例如,它可以影响颗粒在体内的识别和命运,或磷脂成分的酶促水解。目前处于高级临床试验阶段的碳氟化合物的主要应用包括用于向有缺氧风险的组织输送氧气的可注射乳液;用于通过液体通气治疗急性呼吸衰竭的纯碳氟化合物;以及用作超声成像造影剂的气态碳氟化合物稳定的微泡。含氟表面活性剂还可以制备一系列稳定的直接和反向乳液、微乳液、多重乳液和凝胶,其中一些可能同时包含碳氟化合物、烃和水相。高度氟化的系统具有输送药物、前药、疫苗、基因、标记物、造影剂和其他材料的潜力。